Graves Ophthalmopathy study: Bimatoprost Ophthalmic
Official title Bimatoprost as a Treatment for Graves' Orbitopathy
ClinicalTrials.gov ID: NCT03708627
What this study is testing
What is Bimatoprost Ophthalmic?
This is an investigational eye drop being studied to see if it can help shrink fat around the eyes in people with Graves' disease. It is designed to lower pressure inside the eye by helping fluid drain out.
Also referred to as Lumigan.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to see if the eye drop can cause fat loss around the eyes in people with Graves' ophthalmopathy.
- Who it's for
- Adults with Graves' disease that causes eye problems.
- What's involved
- Participants will use Bimatoprost eye drops on the eye area and may have eye exams and measurements.
- Time commitment
- The study lasts a few weeks to months with regular visits for eye checks.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Graves' Ophthalmopathy with Exophthalmos/Proptosis -
You likely can't join if
- Active Graves Disease, Currently pregnant, Taking Steroids
The study team makes the final eligibility decision.
Where it is enrolling
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Seattle, Washington, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.